Analyze Publications Database

In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography

Barthel H, Wilson H, Collingridge DR, Brown G, Osman S, Luthra SK, Brady F, Workman P, Price PM, Aboagye EO. In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography. Br J Cancer. June 2004;90(11):2232-2242.

Full Text – Open Access

Publication Date
June 2004

How Analyze was Used
“The image data sets obtained were transferred to a SUN workstation … and visualised using the ANALYZE software (Version 5.0).”

Keywords
Animals
Breast Neoplasms/radionuclide imaging
Cell Hypoxia
Etanidazole/analogs & derivatives/diagnostic use/pharmacokinetics
Fibrosarcoma/radionuclide imaging
Fluorine Radioisotopes/diagnostic use/pharmacokinetics
Mice
Mice, Inbred BALB C
Neoplasms, Experimental
Tomography, Emission-Computed
Transplantation, Heterologous

Author Affiliation(s)
Cancer Research UK PET Oncology Group, Department of Cancer Medicine, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, W12 0NN London, UK. (HB, DRC, PMP, EOA)

Hammersmith Imanet, Cyclotron Building, Hammersmith Hospital, Du Cane Road, W12 0NN London, UK. (HW, GB, SO, SKL, FB)

Cancer Research UK Centre for Cancer Therapeutics, The Institute for Cancer Research, Brookes Lawley Building, Room 0E8, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK. (PW)

Department of Nuclear Medicine, University of Leipzig, Liebigstraße 20A, 04103 Leipzig, Germany. (HB)

ID# 2305

Tags: , , , , , , , , , ,